tiprankstipranks
Trending News
More News >

New Portfolio - New Portfolio

dya

New Portfolio
Individual Investor
Ranked #123,171 out of 834,043 TipRanks' Investors
Success Rate
48%
416 out of 862
profitable transactions
Average Return
60.75%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 2.31%
6-Month Return▲ 31.94%
12-Month Return▲ 33.61%
YTD Return▲ 33.91%
Total Return▲ 296.50%

Best Trade

Opened at
Closed at-
Gain▲ 7052.03%

Bio

Primarily growth stocks for long term commitment; some sector leaders that I may rotate in or out.

Performance

12.88%0-12.88%
▲ 11.63%
▲ 6.28%
▲ 3.28%
May 2025
▲ 9.25%
▲ 5.14%
▲ 8.99%
Jun 2025
▲ 7.60%
▲ 2.30%
▲ 3.22%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 6.83%
Aug 2025
▲ 12.88%
▲ 3.56%
▲ 7.77%
Sep 2025
▲ 10.96%
▲ 2.38%
▲ 5.74%
Oct 2025
▼ 3.57%
▲ 0.19%
▲ 2.63%
Nov 2025
▲ 1.55%
▲ 1.31%
▲ 2.31%
Dec 2025
TipRanks AverageS&P 500Investor Portfolio
▲ 11.63%▲ 6.28%▲ 3.28%
▲ 9.25%▲ 5.14%▲ 8.99%
▲ 7.60%▲ 2.30%▲ 3.22%
▲ 2.76%▲ 2.05%▲ 6.83%
▲ 12.88%▲ 3.56%▲ 7.77%
▲ 10.96%▲ 2.38%▲ 5.74%
▼ 3.57%▲ 0.19%▲ 2.63%
▲ 1.55%▲ 1.31%▲ 2.31%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Nuvation Bio
▲ 207.29%
6
Close
Dec 26, 2025
uniQure
0.12%
0.00%
1
Open
Dec 26, 2025
Cullinan Management
0.12%
▲ 3.70%
1
Open
Dec 23, 2025
Ascendis Pharma
▲ 89.72%
6
Close
Dec 12, 2025
Iovance Biotherapeutics
0.31%
▼ 22.37%
8
Buy
Dec 12, 2025
Kura Oncology
0.24%
▼ 0.13%
6
Buy
Dec 09, 2025
Telix Pharmaceuticals
0.18%
▼ 16.60%
2
Buy
Dec 09, 2025
Replimune Group
▲ 9.50%
9
Close
Dec 03, 2025
ARS Pharmaceuticals
▼ 1.75%
3
Close
Dec 03, 2025
Wave Life Sciences
▼ 29.28%
3
Close
Dec 03, 2025
KalVista Pharmaceuticals
▲ 28.66%
3
Close
Dec 03, 2025
Matador Resources
0.51%
▲ 372.60%
8
Buy
Nov 24, 2025
MP Materials
0.25%
▼ 7.23%
1
Open
Nov 13, 2025
Apellis Pharmaceuticals
0.24%
▲ 27.99%
1
Open
Nov 11, 2025
Biohaven Ltd.
▲ 22.42%
2
Close
Oct 31, 2025
Tarsus Pharmaceuticals
▲ 92.67%
5
Close
Oct 21, 2025
Journey Medical Corp
0.25%
▲ 6.33%
2
Buy
Oct 21, 2025
Arcutis Biotherapeutics
▲ 164.54%
6
Close
Oct 07, 2025
Arrowhead Pharmaceuticals
▲ 60.71%
15
Close
Sep 24, 2025
Corvus Pharmaceuticals
▼ 17.38%
7
Close
Sep 24, 2025